Status:
NOT_YET_RECRUITING
Creos Xenoprotect PMCF
Lead Sponsor:
Nobel Biocare
Conditions:
Bone Regeneration
Dental Implants
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this retrospective PMCF study is to assess safety and performance of creos xenoprotect in all indications functioning as dental barrier membrane. The primary endpoint of the study is the ...
Eligibility Criteria
Inclusion
- Participant was treated before December 2023 (creos xenoprotect placement)
- Participant signed informed consent form and data protection consent form1
- Participant was at least 18 years old at the time of treatment
- Participant received guided bone regeneration combined with the use of creos xenoprotect according to one of the four indications
- Participant was treated according to instructions for use (IFU)
- Participant should have follow-up time of \>9 months after placement of the investigational device
Exclusion
- In Group 3: Sinus floor augmentation (lateral approach): usage of creos xenoprotect to replace a ruptured Schneiderian Membrane
Key Trial Info
Start Date :
November 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07153185
Start Date
November 1 2025
End Date
July 31 2026
Last Update
September 3 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.